Literature DB >> 17047430

[The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years].

You Sik Choi1, Jae Hee Cheon, Jong Yeul Lee, Sang Gyun Kim, Joo Sung Kim, Nayoung Kim, Dong Ho Lee, Jung Mogg Kim, Hyun Chae Jung, In Sung Song.   

Abstract

BACKGROUND/AIMS: The prevalence of antibiotic resistance in Helicobacter pylori (H. pylori) infection has been reported to be increasing. However, the recent trend of eradication rates of H. pylori using first-line triple regimens has been rarely issued. Therefore, we aimed to determine the trend of H. pylori eradication rates in single center for recent eight years.
METHODS: From January 1998 through October 2005, H. pylori eradication rates in 525 patients with H. pylori-positive peptic ulcer disease who received one-week triple regimens were retrospectively evaluated according to years, regimens, and ulcer locations.
RESULTS: The overall H. pylori eradication rate was 78.7%. Yearly eradication rates from the year 1998 to 2005 were 83.7%, 80.4%, 81.4%, 78.8%, 75.3%, 77.6%, 78.9% and 77.6% consecutively by per-protocol analysis, However, no definite evidence of decreasing tendency of eradication rate was seen during the past eight years (p=0.419). Furthermore, there was no significant difference in the eradication rates according to the ulcer locations and regimens.
CONCLUSIONS: Although it is found that there is no definite statistical evidence of decreasing trend for H. pylori eradication rate during past eight years, those for recent 5 years were lower than 80%, which suggests that we should scrutinize the trend of first-line H. pylori eradication rate, and concern for the expected lower rates in the near future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047430

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  13 in total

1.  Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.

Authors:  Jae Jin Hwang; Dong Ho Lee; Ae-Ra Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

2.  Reinfection rate and endoscopic changes after successful eradication of Helicobacter pylori.

Authors:  Kum Hei Ryu; Sun Young Yi; Youn Ju Na; Su Jung Baik; Su Jin Yoon; Hae-Sun Jung; Hyun Joo Song
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

3.  Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.

Authors:  Ju Yup Lee; Nayoung Kim; Min Soo Kim; Yoon Jin Choi; Jung Won Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Hyun Chae Jung
Journal:  Dig Dis Sci       Date:  2014-03-06       Impact factor: 3.199

4.  Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori.

Authors:  Sang-Pil Yun; Han Gyung Seon; Chang Soo Ok; Kwang Ho Yoo; Min Kyung Kang; Won Hee Kim; Chang Il Kwon; Kwang Hyun Ko; Seong Gyu Hwang; Pil Won Park; Sung Pyo Hong
Journal:  Gut Liver       Date:  2012-10-18       Impact factor: 4.519

5.  Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication.

Authors:  Young Woon Chang; Ga Young Shin; Jung-Wook Kim; Jin-Chang Moon; Eun Jee Chang; Chi Hyuk Oh; Jae-Young Jang
Journal:  Dig Dis Sci       Date:  2021-03-23       Impact factor: 3.199

6.  Dual therapy trial using esomeprazole and amoxicillin as third-line rescue therapy for Helicobacter pylori infection.

Authors:  Hyun Kyung Park; Dong Ho Lee; Seungchul Suh; Pyoung Ju Seo; Nayoung Kim; Sook-Hyang Jeong; Jin-Wook Kim; Jin-Hyeok Hwang; Young Soo Park; Sang Hyub Lee; Cheol Min Shin
Journal:  Clin Endosc       Date:  2011-09-30

7.  Antibiotic resistance in Helicobacter pylori strains and its effect on H. pylori eradication rates in a single center in Korea.

Authors:  Byoungrak An; Byung Soo Moon; Heejung Kim; Hyun Chul Lim; Yong Chan Lee; Gyusang Lee; Sa-Hyun Kim; Min Park; Jong Bae Kim
Journal:  Ann Lab Med       Date:  2013-10-17       Impact factor: 3.464

8.  Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?

Authors:  Eun Jeong Gong; Sung-Cheol Yun; Hwoon-Yong Jung; Hyun Lim; Kwi-Sook Choi; Ji Yong Ahn; Jeong Hoon Lee; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Jin-Ho Kim
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

9.  Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea.

Authors:  Kyu-Hyun Yoon; Sung Woon Park; Sang Wook Lee; Beom Jin Kim; Jae Gyu Kim
Journal:  J Korean Med Sci       Date:  2014-09-02       Impact factor: 2.153

10.  Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy.

Authors:  Sung Eun Kim; Moo In Park; Seun Ja Park; Won Moon; Youn Jung Choi; Ji Hyun Cheon; Hye Jung Kwon; Ki Hwan Ku; Chang Hun Yoo; Jae Hyun Kim; Gyu Won Lee; Sung Eun Song
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.